Functional role of lncRNA MEG3 on pyroptosis through interacting with EZH2 and YTHDC1 in postoperative cognitive dysfunction
View abstract on PubMed
Summary
This summary is machine-generated.Long non-coding RNA MEG3 inhibits neuroinflammation and protects against postoperative cognitive dysfunction (POCD) by suppressing the NLRP3 inflammasome pathway. This discovery offers a potential therapeutic target for POCD treatment.
Area Of Science
- Neuroscience
- Molecular Biology
- Genetics
Background
- Postoperative cognitive dysfunction (POCD) mechanisms are unclear, limiting effective treatments.
- Neuroinflammation-induced NLRP3 pyroptosis pathway contributes to POCD development.
- Long non-coding RNA MEG3's role in neurological injury and pyroptosis requires further investigation.
Purpose Of The Study
- To investigate the molecular mechanisms of lncRNA MEG3 in sevoflurane-induced POCD.
- To elucidate the role of MEG3 in regulating NLRP3 inflammasome and pyroptosis in hippocampal neurons.
- To explore MEG3 as a potential therapeutic target for POCD.
Main Methods
- Sevoflurane-induced in vitro and in vivo POCD models.
- Quantitative real-time PCR (qRT-PCR), Western blot, ELISA, and histological staining for gene and protein expression.
- Cell viability (CCK-8) and injury (LDH) assays, Morris Water Maze (MWM) test for cognitive function.
- RNA immunoprecipitation (RIP) and chromatin immunoprecipitation (ChIP) to validate molecular interactions.
Main Results
- Sevoflurane reduced MEG3 and pyroptosis markers in mice.
- MEG3 overexpression ameliorated sevoflurane-induced cognitive deficits and pyroptosis.
- MEG3 downregulated NLRP3 expression by reducing mRNA stability via EZH2/YTHDC1 interaction.
Conclusions
- MEG3 inhibits NLRP3 inflammasome and hippocampal neuron pyroptosis by recruiting EZH2/YTHDC1.
- MEG3 plays a crucial role in regulating POCD.
- MEG3 presents a promising therapeutic target for treating POCD.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

